Can art truly heal? It’s a question that’s been quietly simmering in the medical world for decades, and now, a groundbreaking partnership between the Rijksmuseum and a team of researchers is poised to shed new light on this intriguing possibility. Since the 1970s, physicians have observed a curious phenomenon: some individuals diagnosed with Parkinson’s Disease, a progressive movement disorder, report feeling a surge in creativity after their diagnosis. But here’s where it gets fascinating—this observation wasn’t just a footnote in medical journals; it sparked a full-fledged investigation into how creativity might influence health outcomes for Parkinson’s patients.
A few years ago, a Dutch research team, including neuroscientist Blanca Spee, Parkinson’s expert Bas Bloem, epidemiologist Sirwan Darweesh, and artist Marjoke Plijnaer, embarked on a long-term study to explore this connection. Between March 2021 and March 2022, they tracked 800 Parkinson’s patients, meticulously documenting changes in their creative expression. The results were eye-opening: 41 percent of participants reported shifts in their creativity, with 12 percent experiencing a boost, 22 percent a decline, and 7 percent noticing fluctuations. Interestingly, those taking dopamine agonists were more likely to report increased creativity. This led the team to propose a bold idea: what if creativity could be both a marker of health and a therapeutic tool for Parkinson’s patients?
Building on this hypothesis, the researchers created a ‘creative playground,’ a 10-week program where participants engaged in activities like painting, music-making, and writing. The findings, published in January, were striking: participants reported reduced anxiety, an enhanced sense of well-being, and even slight improvements in cognitive function. Fewer doctor visits were just the cherry on top.
And this is the part most people miss—the study’s impact didn’t go unnoticed. On November 17, the Michael J. Fox Foundation awarded Bas Bloem the prestigious Pritzker Prize, along with a $200,000 grant, for his pioneering work on holistic Parkinson’s care. This funding will fuel the team’s next ambitious project: an 18-month study involving three groups of participants. One group will explore the Rijksmuseum’s art collection, another will create art, and a control group will engage with art in neither way. The museum is stepping up too, offering participants free annual passes and exclusive crowd-free evenings to enjoy the collection.
But here’s the controversial part: can simply viewing or creating art significantly impact health outcomes? While the initial findings are promising, skeptics argue that the benefits might be placebo or short-lived. And what about accessibility? Not everyone has access to world-class museums or art programs. Is this a privilege reserved for the few, or can these findings be scaled to benefit a broader population?
As the study unfolds, one thing is clear: the intersection of art and health is far more complex—and potentially transformative—than we ever imagined. What do you think? Could art be the next frontier in medical therapy, or is it just another well-intentioned experiment? Let’s discuss in the comments!
